GSK1904529A, an insulin‑like growth factor‑1 receptor inhibitor, inhibits glioma tumor growth, induces apoptosis and inhibits migration

Zhou,Qiang; Zhang,Junxia; Cui,Qinying; Li,Xiaodong; Gao,Ge; Wang,Yanfen; Xu,Yuping; Gao,Xiaoqun

doi:10.3892/mmr.2015.3869

September-2015 Volume 12 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-2015 Volume 12 Issue 3

Full Size Image

Article Open Access

GSK1904529A, an insulin‑like growth factor‑1 receptor inhibitor, inhibits glioma tumor growth, induces apoptosis and inhibits migration

Authors:
- Qiang Zhou
- Junxia Zhang
- Qinying Cui
- Xiaodong Li
- Ge Gao
- Yanfen Wang
- Yuping Xu
- Xiaoqun Gao
View Affiliations / Copyright

Affiliations: Department of Pathology, Children's Hospital of Zhengzhou, Zhengzhou, Henan 450052, P.R. China, Department of Anatomy, Basic Medical College, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China, Department of Ophthalmology, People's Hospital of Zhengzhou, Zhengzhou, Henan 450012, P.R. China, Department of Physiology, Basic Medical College, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China, Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, P.R. China

Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
Pages: 3381-3385
|
Published online on: May 28, 2015

https://doi.org/10.3892/mmr.2015.3869
Expand metrics +

Abstract

Malignant gliomas are the most common type of primary malignancy of the central nervous system, with a poor prognosis. The therapeutic options for malignant gliomas are limited and far from satisfactory, and novel treatment strategies are urgently required to improve the outcome of the disease. Insulin‑like growth factor (IGF)/IGF‑1 receptor (IGF‑1R) signaling pathway regulates cell proliferation, motility and survival. The dysregulation of this signaling pathway has been implicated in the development of malignant gliomas. In the present study, GSK1904529A, a small molecule inhibitor of IGF‑1R, suppressed glioma cell viability, induced glioma cell apoptosis and inhibited glioma cell migration in vitro. In addition, GSK1904529A inhibited glioma tumor growth and induced tumor cell apoptosis in vivo. In conclusion, the results of the present study suggested GSK1904529A as a promising agent for the treatment of malignant glioma.

View Figures

View References

1	Dolecek TA, Propp JM, Stroup NE and Kruchko C: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 14(Suppl 5): v1–v49. 2012. View Article : Google Scholar :
2	Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
3	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
4	Omuro A and DeAngelis LM: Glioblastoma and other malignant gliomas: A clinical review. JAMA. 310:1842–1850. 2013. View Article : Google Scholar : PubMed/NCBI
5	Anton K, Baehring JM and Mayer T: Glioblastoma multiforme: Overview of current treatment and future perspectives. Hematol Oncol Clin North Am. 26:825–853. 2012. View Article : Google Scholar : PubMed/NCBI
6	Tognon CE and Sorensen PH: Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin Ther Targets. 16:33–48. 2012. View Article : Google Scholar : PubMed/NCBI
7	Maki RG: Small is beautiful: Insulin-like growth factors and their role in growth, development and cancer. J Clin Oncol. 28:4985–4995. 2010. View Article : Google Scholar : PubMed/NCBI
8	Miller BS and Yee D: Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res. 65:10123–10127. 2005. View Article : Google Scholar : PubMed/NCBI
9	Wang Y and Sun Y: Insulin-like growth factor receptor-1 as an anti-cancer target: Blocking transformation and inducing apoptosis. Curr Cancer Drug Targets. 2:191–207. 2002. View Article : Google Scholar : PubMed/NCBI
10	Trojan J, Cloix JF, Ardourel MY, Chatel M and Anthony DD: Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience. 145:795–811. 2007. View Article : Google Scholar : PubMed/NCBI
11	Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R and Rubin R: Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 54:2218–2222. 1994.PubMed/NCBI
12	Hägerstrand D, Lindh MB, Peña C, Garcia-Echeverria C, Nistér M, Hofmann F and Ostman A: PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541. Neuro Oncol. 12:967–975. 2010. View Article : Google Scholar : PubMed/NCBI
13	Bielen A, Perryman L, Box GM, Valenti M, de Haven Brandon A, Martins V, Jury A, Popov S, Gowan S, Jeay S, et al: Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β. Mol Cancer Ther. 10:1407–1418. 2011. View Article : Google Scholar : PubMed/NCBI
14	Shi ZM, Wang XF, Qian X, Tao T, Wang L, Chen QD, Wang XR, Cao L, Wang YY, Zhang JX, Jiang T, et al: MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. RNA. 19:552–560. 2013. View Article : Google Scholar : PubMed/NCBI
15	Sabbatini P, Rowand JL, Groy A, Korenchuk S, Liu Q, Atkins C, Dumble M, Yang J, Anderson K, Wilson BJ, et al: Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase. Clin Cancer Res. 15:3058–3067. 2009. View Article : Google Scholar : PubMed/NCBI
16	Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B and Baserga R: Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol. 19:7203–7215. 1999.PubMed/NCBI
17	Meyer GE, Shelden E, Kim B and Feldman EL: Insulin-like growth factor I stimulates motility in human neuroblastoma cells. Oncogene. 20:7542–7550. 2001. View Article : Google Scholar : PubMed/NCBI
18	Prabhu S, Harris F, Lea R and Snape TJ: Small-molecule clinical trial candidates for the treatment of glioma. Drug Discov Today. 19:1298–1308. 2014. View Article : Google Scholar : PubMed/NCBI